Related Experiment Video
Updated: Oct 3, 2025
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.6K
Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
Jorge Espinosa-Espinosa1,2, Anchel González-Barriga3, Arturo López-Castel1,2
1University Research Institute for Biotechnology and Biomedicine (BIOTECMED), Universidad de Valencia, 46100 Valencia, Spain.
International Journal of Molecular Sciences
|February 15, 2022
Summary
Omics studies are vital for understanding myotonic dystrophy type 1 (DM1), revealing molecular changes and aiding drug development. Future technologies promise further advances in DM1 research and treatment strategies.
Area of Science:
- Genomics and Molecular Biology
- Biomedical Research
Background:
- Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy.
- DM1 is a complex multisystem disease with various molecular underpinnings.
Purpose of the Study:
- To summarize the role of omics studies in understanding DM1.
- To highlight the impact of omics on drug development for DM1.
- To discuss future technological impacts on DM1 research.
Main Methods:
- Utilizing omics approaches (gene expression, microRNA, splicing, methylation, proteomics) on patient samples and animal models.
- Analyzing omics data from drug candidate treatment experiments.
- Reviewing innovative technologies like single-cell sequencing and AI.
Main Results:
- Omics studies have identified numerous molecular alterations contributing to DM1.
- Omics characterization of treatments reveals therapeutic rescue and off-target effects.
- Emerging technologies are poised to significantly advance DM1 research.
Conclusions:
- Omics studies are indispensable for unraveling DM1 pathogenesis.
- Omics data guides the development and evaluation of DM1 therapies.
- Advanced technologies will accelerate future discoveries in DM1.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
01:13Formation of Muscle Fibers from Myoblasts
5.3K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.3K